Literature DB >> 15342000

Biological effects of induction immunosuppression.

Douglas A Hale1.   

Abstract

The concept of induction immunosuppression is evolving. Once used to buttress the inadequacies of past maintenance immunosuppressive regimens, it is now being used to permit effective maintenance immunosuppression using ever decreasing amounts of modern agents. In addition to lymphocyte depletion, with which it was once synonymous, it is now recognized that induction immunosuppression is associated with a host of non-depletional effects such as receptor modulation and blockade, which profoundly alter the lymphocyte's capacity to mount an effective response. Additionally, the recent focus on the effect of induction agents on antigen presenting cells and on regulatory factors controlling homeostatic repopulation may ultimately permit a safer, more refined and more effective approach to induction immunosuppression.

Mesh:

Substances:

Year:  2004        PMID: 15342000     DOI: 10.1016/j.coi.2004.07.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  4 in total

1.  Immune reconstitution following rabbit antithymocyte globulin.

Authors:  S Gurkan; Y Luan; N Dhillon; S R Allam; T Montague; J S Bromberg; S Ames; S Lerner; Z Ebcioglu; V Nair; R Dinavahi; V Sehgal; P Heeger; B Schroppel; B Murphy
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

Review 2.  Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.

Authors:  Joshua M Rosenblum; Allan D Kirk
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 3.  Induction therapy in renal transplant recipients: how convincing is the current evidence?

Authors:  Steven J Wagner; Daniel C Brennan
Journal:  Drugs       Date:  2012-03-26       Impact factor: 11.431

4.  Deconvoluting post-transplant immunity: cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells.

Authors:  Yevgeniy A Grigoryev; Sunil M Kurian; Zafi Avnur; Dominic Borie; Jun Deng; Daniel Campbell; Joanna Sung; Tania Nikolcheva; Anthony Quinn; Howard Schulman; Stanford L Peng; Randolph Schaffer; Jonathan Fisher; Tony Mondala; Steven Head; Stuart M Flechner; Aaron B Kantor; Christopher Marsh; Daniel R Salomon
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.